BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9658519)

  • 1. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
    Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M; Tanaka K; Tsuji S
    Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Nakajima T; Yamazaki M; Miyatake T; Tsuji S
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
    Cohen AB; Zupa-Fernandez A; Dalmau J; Galetta SL
    J Neurol Sci; 2004 Oct; 225(1-2):153-5. PubMed ID: 15465100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
    Matsushita H; Kodama S; Aoki Y; Tanaka K; Tanaka K; Saito N
    Gynecol Obstet Invest; 1998; 45(2):140-3. PubMed ID: 9517809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
    Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
    Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
    Storstein A; Monstad SE; Honnorat J; Vedeler CA
    J Neuroimmunol; 2004 Oct; 155(1-2):150-4. PubMed ID: 15342206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W; Drlicek M; Liszka U
    Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.